Leonard Gilroy

@ReasonFdn VP of Gov Reform & Senior Managing Director of Reason's Pension Integrity Project @ReasonPensions

[Reason Foundation @ReasonFdn]

Local governments across the 50 states collected $8.3 billion in fines and forfeitures in fiscal year 2022. While fines represent just 0.38% of general revenue on average, reliance is heavily concentrated in a small number of jurisdictions.

https://t.co/wEl5cBBupY

[Leonard Gilroy @lengilroy]

Read the full article here: https://t.co/FRhZ7bk2Lh

[Leonard Gilroy @lengilroy]

Illinois: Don’t let Social Security safe harbor compliance become a blank check for Tier 2 benefit expansion -
"...[e]ven granting that the salary-cap issue creates a genuine compliance risk, Rev. Proc. 91-40’s mechanical tests require only that the initial annual annuity meet a baseline comparable to Social Security’s Primary Insurance Amount. Nothing in the minimum benefit framework mandates shorter averaging periods, earlier unreduced retirement, richer COLAs, or any of the rollbacks of the 2011 pension reforms now on the table. Those are discretionary policy choices. Treating federal minimum benefit compliance as a blank check for undoing prior reforms  misuses a narrow regulatory concern to bypass the hard trade-offs that should govern public pension design..." via @ReasonFdn @ReasonPensions

[Reason Foundation @ReasonFdn]

With taxpayers responsible for public pension debt, what role, if any, should crypto investments play in public retirement systems managing trillions of dollars in assets?

Join us June 23 for a discussion featuring @NCTreasurer @brad_briner, @MariiFTrujillo, @lengilroy, and Todd Kanaster of @SPGlobal.

Register here:

https://t.co/xbI4KOehay

[Reason Foundation @ReasonFdn]

Join @MariiFTrujillo and @lengilroy of @ReasonFdn on June 23 for a discussion on one of the biggest emerging questions in public finance: Should public pension systems invest in cryptocurrencies such as Bitcoin?

We'll explore how they can manage risks, fiduciary responsibilities, transparency challenges, and the potential implications for workers, retirees, and taxpayers.

https://t.co/xbI4KOehay

[Reason Foundation @ReasonFdn]

How should public pension systems approach investments in Bitcoin, Ethereum, and other digital assets?

Join us June 23 for a live discussion featuring @NCTreasurer @brad_briner, @SPGlobal’s Todd Kanaster, and @ReasonFdn’s @lengilroy and @MariiFTrujillo on the risks, rewards, and transparency challenges surrounding crypto investments.

https://t.co/xbI4KOehay

[U.S. FDA @US_FDA]

Following President Trump’s directive to accelerate medical treatments for serious mental illnesses, FDA announced major steps to support the development of serotonin-2A agonists & related products—a class of medications historically referred to as "psychedelic" drugs.

✅ National priority vouchers for psilocybin (for treatment-resistant depression and major depressive disorder)
✅ National priority voucher for methylone (for post-traumatic stress disorder)
✅ First-ever noribogaine study authorized for alcohol use disorder
✅ Advancing guidance for sponsors developing these products

Learn more: https://t.co/GZobFZ67Gh

[NBC News @NBCNews]

LATEST: The FDA grants a quick review of three experimental psychedelic drugs meant to treat major depression and post-traumatic stress disorder. https://t.co/PQ7BoLWIDr

[Reason Foundation @ReasonFdn]

This is a historic step toward a more rational federal approach to marijuana policy.

However, recreational marijuana consumers and businesses gain no relief. Cannabis for non-medical use remains Schedule I, and possession without a state-issued medical authorization remains a federal crime.

https://t.co/ZaeED6EkZL

[Reason Foundation @ReasonFdn]

“In a move that would have seemed unthinkable a decade ago, the Trump administration has officially rescheduled state-licensed medical marijuana from Schedule I to Schedule III,” write @michelleminton and @GLawNV.

https://t.co/BFOOVW6iaS

[American Legislative Exchange Council @ALEC_states]

For veterans, first responders, and others suffering from serious treatment-resistant mental health conditions, the EO represents hope for real progress on emerging treatments. @federico_zach explains what this means for research and patient access.
https://t.co/dFkAPw2j9p

[Geoffrey Lawrence @GLawNV]

Ultimate example of tribe over principle.

I applauded Joe Biden when he ordered a rescheduling review for MJ and also the Trump admin for the 2 orders this week, because they were all productive.

If your ideas only go as deep as your tribe, I’m uninterested in your opinion.

[MAHA Action @MAHA_Action]

“We’ve lost more veterans to suicide since the Iraq and Afghan wars than from the actual wars.”

Dr. Marty Makary puts it bluntly: we’ve failed veterans on mental health, and it’s time to explore promising therapies like psychedelics.

“For many of these veterans, the wars are over, but the men and women are still dying.”

“The battle rages inside their brain.”

“We set aside $50 million… for new research.”

“We want to understand… why these medications might potentially help them.”

[Leonard Gilroy @lengilroy]

https://t.co/d8IvUCSz0T

[Leonard Gilroy @lengilroy]

Right to Try. Priority Review Vouchers. $50M in federal research dollars. Rescheduling directives. @GLawNV and I break down Trump's new executive order on psychedelics and what it could actually mean in practice →

[Jude Schwalbach @JudeSchwalbach]

Here’s the state by state estimated percent change in public school enrollment

[Leonard Gilroy @lengilroy]

…and be sure to check out the sage @nickgillespie perspective here: https://t.co/yr03umybzR

[Leonard Gilroy @lengilroy]

https://t.co/d8IvUCSz0T

[Leonard Gilroy @lengilroy]

In an unusual twist, a Republican administration just directed federal agencies to accelerate access to ibogaine and other psychedelics as potential treatments for various mental health conditions. @GLawNV and I have a new article explaining what Trump’s new EO actually does, implications for state-level psychedelic policy reform, and why it could stand among the most consequential drug policy shifts of the last several decades.

[Reason Foundation @ReasonFdn]

"These therapies hold the potential to help Americans break free of the country’s major mental health challenges, including opioid addiction."
— @lengilroy and @GLawNV

https://t.co/uCIGY3PXcq